Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)

Autor: Xiong, S., Yang, H., Westland, C.E., Delaney, W.E., IV, Colledge, D., Bartholomeusz, A., Thibault, V., Benhamou, Y., Angus, P., Wulfsohn, M., Gibbs, C.S., Fry, J., Brosgart, C.L., Locarnini, S.
Zdroj: In Journal of Hepatology 2003 38 Supplement 2:182-182
Databáze: ScienceDirect